Kalray Valuation

Is 0ABT undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

3/6

Valuation Score 3/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 0ABT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 0ABT's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 0ABT's fair value for valuation analysis.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 0ABT?

Key metric: As 0ABT is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 0ABT. This is calculated by dividing 0ABT's market cap by their current revenue.
What is 0ABT's PS Ratio?
PS Ratio0.3x
Sales€37.29m
Market Cap€10.16m

Price to Sales Ratio vs Peers

How does 0ABT's PS Ratio compare to its peers?

The above table shows the PS ratio for 0ABT vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average2x
NANO Nanoco Group
2.6xn/aUK£20.3m
CYAN CyanConnode Holdings
1.9x47.0%UK£35.3m
KMK Kromek Group
1.9xn/aUK£36.2m
ENSI EnSilica
1.6x15.0%UK£41.5m
0ABT Kalray
0.3x10.1%€9.4m

Price-To-Sales vs Peers: 0ABT is good value based on its Price-To-Sales Ratio (0.3x) compared to the peer average (2x).


Price to Sales Ratio vs Industry

How does 0ABT's PS Ratio compare vs other companies in the European Semiconductor Industry?

5 CompaniesPrice / SalesEstimated GrowthMarket Cap
0ABT 0.3xIndustry Avg. 1.7xNo. of Companies8PS012345+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: 0ABT is good value based on its Price-To-Sales Ratio (0.3x) compared to the European Semiconductor industry average (1.7x).


Price to Sales Ratio vs Fair Ratio

What is 0ABT's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

0ABT PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.3x
Fair PS Ratio1.1x

Price-To-Sales vs Fair Ratio: 0ABT is good value based on its Price-To-Sales Ratio (0.3x) compared to the estimated Fair Price-To-Sales Ratio (1.1x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 0ABT forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€1.06
€4.13
+289.9%
71.3%€8.30€2.00n/a3
Nov ’25€1.07
€4.13
+287.0%
71.3%€8.30€2.00n/a3
Oct ’25€2.17
€4.13
+90.9%
71.3%€8.30€2.00n/a3
Sep ’25€5.78
€12.03
+108.2%
22.6%€15.60€9.00n/a3
Aug ’25€8.18
€15.37
+87.9%
20.0%€19.00€11.50n/a3
Jul ’25€11.10
€20.33
+83.2%
5.9%€22.00€19.30n/a3
Jun ’25€17.86
€22.40
+25.4%
17.7%€28.00€19.30n/a3
May ’25€17.16
€22.40
+30.5%
17.7%€28.00€19.30n/a3
Apr ’25€15.90
€22.80
+43.4%
16.2%€28.00€19.90n/a3
Mar ’25€19.70
€22.97
+16.6%
15.6%€28.00€19.90n/a3
Feb ’25€19.46
€22.97
+18.0%
15.6%€28.00€19.90n/a3
Jan ’25€20.70
€27.40
+32.4%
13.4%€32.00€23.00n/a3
Dec ’24€23.42
€27.40
+17.0%
13.4%€32.00€23.00n/a3
Nov ’24€18.26
€30.33
+66.1%
17.9%€36.00€23.00€1.073
Oct ’24€21.98
€30.33
+38.0%
17.9%€36.00€23.00€2.173
Sep ’24€29.10
€37.50
+28.9%
2.9%€38.50€36.00€5.783
Aug ’24€30.15
€37.50
+24.4%
2.9%€38.50€36.00€8.183
Jul ’24€28.25
€34.50
+22.1%
10.3%€38.00€29.60€11.103
Jun ’24€22.30
€31.70
+42.2%
6.6%€33.80€29.60€17.862
May ’24€16.06
€31.70
+97.4%
6.6%€33.80€29.60€17.162
Apr ’24€15.82
€31.80
+101.0%
6.9%€34.00€29.60€15.902
Mar ’24€17.72
€32.70
+84.5%
4.0%€34.00€31.40€19.702
Feb ’24€20.40
€32.70
+60.3%
4.0%€34.00€31.40€19.462
Jan ’24€17.35
€32.05
+84.7%
2.0%€32.70€31.40€20.702
Dec ’23n/a
€32.05
0%
2.0%€32.70€31.40€23.422
Nov ’23n/a
€33.60
0%
2.7%€34.50€32.70€18.262

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies